Search

Vocal fold motion impairment following intubation – how likely is it to recover?

Ed’s Choice reviews a timely paper investigating prolonged intubation on vocal fold motion. The current scientific literature is dominated by studies examining COVID-19 and its widespread effects on health and healthcare delivery but will be old news by the time...

Complications associated with intra-tympanic steroid injections for sudden sensorineural hearing loss

Around 15,000 people in the UK experience a sudden sensorineural hearing loss (SSNHL) each year, and in the majority of cases the cause is unknown. Treatment options for idiopathic SSNHL include various modalities of steroid treatments which have known limitations...

Cervicogenic vertigo, a view from the experts

Many readers would be familiar with the term ‘cervicogenic vertigo’ to mean neck-related vertigo or dizziness. In simple terms, this disorder has been defined as dizziness/vertigo caused by neck pain and/or stiffness. By implication, the vertigo/dizziness should resolve by treating...

Metformin, the magical solution!

Both noise-induced hearing loss (NIHL) and vestibular schwannomas (VSs) pose a challenge in terms of management. Metformin was suggested as a potential therapeutic drug for NIHL when the drug-target interaction data was investigated. Additionally, there are studies which demonstrate reduction...

AI in ENT practice

Artificial intelligence (AI) technologies are becoming increasingly prevalent in our lives and there has been both enthusiasm and caution for using AI in healthcare. A recent article in the Journal of the American Medical Association reported on a trial examining...

Extranodal extension following surgical resection of HPV-positive oropharyngeal cancer – is adjuvant radiotherapy alone sufficient?

Human papillomavirus (HPV) is a known aetiological factor in oropharyngeal squamous cell carcinoma (OPSCC). HPV-positive OPSCC is recognised to have a more favourable prognosis than HPV-negative disease. Treatment deintensification for HPV+ OPSCC has therefore been an area of research focus...